Literature DB >> 21949161

Encounter frequency and serum glucose level, blood pressure, and cholesterol level control in patients with diabetes mellitus.

Fritha Morrison1, Maria Shubina, Alexander Turchin.   

Abstract

BACKGROUND: More frequent patient-provider encounters may lead to faster control of hemoglobin A1c level, blood pressure (BP), and low-density lipoprotein (LDL) cholesterol (LDL-C) level (hereafter referred to as hemoglobin A1c, BP, and LDL-C) and improve outcomes, but no guidelines exist for how frequently patients with diabetes mellitus (DM) should be seen.
METHODS: This retrospective cohort study analyzed 26,496 patients with diabetes and elevated hemoglobin A1c, BP, and/or LDL-C treated by primary care physicians at 2 teaching hospitals between January 1, 2000, and January 1, 2009. The relationship between provider encounter (defined as a note in the medical record) frequency and time to hemoglobin A1c, BP, and LDL-C control was assessed.
RESULTS: Comparing patients who had encounters with their physicians between 1 to 2 weeks vs 3 to 6 months, median time to hemoglobin A1c less than 7.0% was 4.4 vs 24.9 months (not receiving insulin) and 10.1 vs 52.8 months (receiving insulin); median time to BP lower than 130/85 mm Hg was 1.3 vs 13.9 months; and median time to LDL-C less than 100 mg/dL was 5.1 vs 32.8 months, respectively (P<.001 for all). In multivariable analysis, doubling the time between physician encounters led to an increase in median time to hemoglobin A1c (not receiving [35%] and receiving [17%] insulin), BP (87%), and LDL-C (27%) targets (P<.001 for all). Time to control decreased progressively as encounter frequency increased up to once every 2 weeks for most targets, consistent with the pharmacodynamics of the respective medication classes.
CONCLUSIONS: Primary care provider encounters every 2 weeks are associated with fastest achievement of hemoglobin A1c, BP, and LDL-C targets for patients with diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21949161      PMCID: PMC3692291          DOI: 10.1001/archinternmed.2011.400

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  58 in total

1.  Primary care--will it survive?

Authors:  Thomas Bodenheimer
Journal:  N Engl J Med       Date:  2006-08-31       Impact factor: 91.245

2.  Perspective roundtable: redesigning primary care.

Authors:  Thomas H Lee; Thomas Bodenheimer; Allan H Goroll; Barbara Starfield; Katharine Treadway
Journal:  N Engl J Med       Date:  2008-11-13       Impact factor: 91.245

3.  Using regular expressions to abstract blood pressure and treatment intensification information from the text of physician notes.

Authors:  Alexander Turchin; Nikheel S Kolatkar; Richard W Grant; Eric C Makhni; Merri L Pendergrass; Jonathan S Einbinder
Journal:  J Am Med Inform Assoc       Date:  2006-08-23       Impact factor: 4.497

4.  Prevalence, treatment, and control of diagnosed diabetes in the U.S. National Health and Nutrition Examination Survey 1999-2004.

Authors:  Kwok Leung Ong; Bernard M Y Cheung; Louisa Y F Wong; Nelson M S Wat; Kathryn C B Tan; Karen S L Lam
Journal:  Ann Epidemiol       Date:  2008-01-16       Impact factor: 3.797

5.  Factors associated with medical students' career choices regarding internal medicine.

Authors:  Karen E Hauer; Steven J Durning; Walter N Kernan; Mark J Fagan; Matthew Mintz; Patricia S O'Sullivan; Michael Battistone; Thomas DeFer; Michael Elnicki; Heather Harrell; Shalini Reddy; Christy K Boscardin; Mark D Schwartz
Journal:  JAMA       Date:  2008-09-10       Impact factor: 56.272

6.  Effect of board certification on antihypertensive treatment intensification in patients with diabetes mellitus.

Authors:  Alexander Turchin; Maria Shubina; Anna H Chodos; Jonathan S Einbinder; Merri L Pendergrass
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

7.  Comparison of information content of structured and narrative text data sources on the example of medication intensification.

Authors:  Alexander Turchin; Maria Shubina; Eugene Breydo; Merri L Pendergrass; Jonathan S Einbinder
Journal:  J Am Med Inform Assoc       Date:  2009-03-04       Impact factor: 4.497

8.  Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.

Authors:  Jianping Weng; Yanbing Li; Wen Xu; Lixin Shi; Qiao Zhang; Dalong Zhu; Yun Hu; Zhiguang Zhou; Xiang Yan; Haoming Tian; Xingwu Ran; Zuojie Luo; Jing Xian; Li Yan; Fangping Li; Longyi Zeng; Yanming Chen; Liyong Yang; Sunjie Yan; Juan Liu; Ming Li; Zuzhi Fu; Hua Cheng
Journal:  Lancet       Date:  2008-05-24       Impact factor: 79.321

9.  Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU).

Authors:  M Marre; J Shaw; M Brändle; W M W Bebakar; N A Kamaruddin; J Strand; M Zdravkovic; T D Le Thi; S Colagiuri
Journal:  Diabet Med       Date:  2009-03       Impact factor: 4.359

10.  Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  David M Nathan; John B Buse; Mayer B Davidson; Ele Ferrannini; Rury R Holman; Robert Sherwin; Bernard Zinman
Journal:  Diabetes Care       Date:  2008-10-22       Impact factor: 17.152

View more
  46 in total

1.  Hydroxyurea and growth in young children with sickle cell disease.

Authors:  Sohail Rana; Patricia E Houston; Winfred C Wang; Rathi V Iyer; Jonathan Goldsmith; James F Casella; Caroline K Reed; Zora R Rogers; Myron A Waclawiw; Bruce Thompson
Journal:  Pediatrics       Date:  2014-09       Impact factor: 7.124

2.  Reducing clinical inertia in hypertension treatment: a pragmatic randomized controlled trial.

Authors:  Amy G Huebschmann; Trina Mizrahi; Alyssa Soenksen; Brenda L Beaty; Thomas D Denberg
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-03-16       Impact factor: 3.738

3.  An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM.

Authors:  Sybil G Hosek; Bret Rudy; Raphael Landovitz; Bill Kapogiannis; George Siberry; Brandy Rutledge; Nancy Liu; Jennifer Brothers; Kathleen Mulligan; Gregory Zimet; Michelle Lally; Kenneth H Mayer; Peter Anderson; Jennifer Kiser; James F Rooney; Craig M Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2017-01-01       Impact factor: 3.731

4.  Variation in nephrologist visits to patients on hemodialysis across dialysis facilities and geographic locations.

Authors:  Kevin F Erickson; Kelvin B Tan; Wolfgang C Winkelmayer; Glenn M Chertow; Jay Bhattacharya
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 8.237

5.  The effect of using a shared electronic health record on quality of care in people with type 2 diabetes.

Authors:  Rebecca F Parker; Abdul Z Mohamed; Salman A Hassoun; Sylvia Miles; Devaka J S Fernando
Journal:  J Diabetes Sci Technol       Date:  2014-05-25

6.  Revisit frequency and its association with quality of care among diabetic patients: Translating Research Into Action for Diabetes (TRIAD).

Authors:  Keiko Asao; Laura N McEwen; Jesse C Crosson; Beth Waitzfelder; William H Herman
Journal:  J Diabetes Complications       Date:  2014-06-19       Impact factor: 2.852

Review 7.  A Practice in Maturation: Current Perspectives on the Transition from Pediatric to Adult Care for Young Adults with Diabetes.

Authors:  Courtney N Sandler; Katharine C Garvey
Journal:  Curr Diab Rep       Date:  2019-11-14       Impact factor: 4.810

8.  Physician-pharmacist collaboration versus usual care for treatment-resistant hypertension.

Authors:  Steven M Smith; Nicholas W Carris; Eric Dietrich; John G Gums; Liz Uribe; Christopher S Coffey; Tyler H Gums; Barry L Carter
Journal:  J Am Soc Hypertens       Date:  2016-01-18

9.  Leveraging electronic health records to develop measurements for processes of care.

Authors:  Ming Tai-Seale; Caroline J Wilson; Laura Panattoni; Nidhi Kohli; Ashley Stone; Dorothy Y Hung; Sukyung Chung
Journal:  Health Serv Res       Date:  2013-11-18       Impact factor: 3.402

10.  Blood Pressure Visit Intensification Study in Treatment: Trial design.

Authors:  Kevin Fiscella; Gbenga Ogedegbe; Hua He; Jennifer Carroll; Andrea Cassells; Mechelle Sanders; Chamanara Khalida; Brianna D'Orazio; Jonathan N Tobin
Journal:  Am Heart J       Date:  2015-09-12       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.